Akiram Therapeutics
Pre-clinicalAkiram Therapeutics pioneers targeted radioimmunotherapy for solid cancers, using innovative radioactive molecules for precise diagnosis and treatment. Discover more about our groundbreaking approach that has shown promising results in preclinical studies.
Founded
2022
Focus
AntibodiesBiologicsDiagnostics
About
Akiram Therapeutics pioneers targeted radioimmunotherapy for solid cancers, using innovative radioactive molecules for precise diagnosis and treatment. Discover more about our groundbreaking approach that has shown promising results in preclinical studies.
Funding History
1Total raised: $2.5M
Seed$2.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2022
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile